Aduhelm Looks Set For Rejection In Europe For Alzheimer's

Adds To US Woes

 
• By Andrew McConaghie
Biogen_Switzerland
Hopes of an EU launch in 2022 are now diminishing, with EU regulators expected to demand a further trial to demonstrate Aduhelm' s efficacy. • Source: Alamy

More from Business

More from Scrip